Form D · Biotechnology
Headlands Holdco, LLC
Boston, MA · CIK 0002145480
Offering snapshot reported Jul 15, 2026 · SEC filing
- Reported sold
- $3.1M Offering amount: $3.1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $3.1M Reported outside-investor minimum
- First sale
- Jun 26, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 15, 2026 | Initial | $3,100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-590876
Source: Form D, filed Jul 15, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kyle Burtnett | Director |
| Peter Mc Lelland | Director |
| Joshua Matthew Nelson | Director, Executive |
| Megan Preiner | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Federal Street 35 Th Floor
Boston, MA, 02110
Phone: 617-227-1050
Boston, MA, 02110
Phone: 617-227-1050